BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 32.80
-1.50 (-4.37%)
At close: Jul 8, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.23 billion as of July 9, 2026. Its market cap has decreased by -26.90% in one year.
Market Cap
2.23B
Enterprise Value
1.18B
Revenue
154.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.80
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.23B, a decrease of -41.65%. That is a compound annual growth rate of -29.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.23B | -43.42% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 33.46B |
| HanchorBio | 24.05B |
| Elixiron Immunotherapeutics (Cayman) Limited | 12.31B |
| Tripartite Therapeutics | 7.51B |
| Uwell Biopharma | 7.45B |
| Intelligene | 6.58B |
| Obigen Pharma | 3.86B |
| Pet Pharm Biotech | 3.10B |